Literature DB >> 21762464

Transfusion-associated circulatory overload after plasma transfusion.

Christina Narick1, Darrell J Triulzi, Mark H Yazer.   

Abstract

BACKGROUND: In 2010, transfusion-associated circulatory overload (TACO) was the second most common cause of transfusion-related mortality reported to the Food and Drug Administration. We sought to determine the rate of TACO caused by plasma transfusion. STUDY DESIGN AND METHODS: This study was conducted in two parts: 1) A retrospective analysis to determine the prevalence of TACO reactions caused by plasma at a tertiary care hospital from 2003 to 2010 was performed by analyzing the blood bank's electronic transfusion reaction records and 2) active surveillance of plasma recipients to determine if unreported TACO reactions had occurred over a 1-month period at the same hospital.
RESULTS: Eighty-seven reactions to plasma had been reported to the blood bank from 2003 through 2010. Of these reactions 23% (20/87) were TACO. The historical prevalence rate of TACO was 1 in 1566 (95% confidence interval [CI], 1:2564-1:1014). During the prospective 1-month surveillance period, 84 patients received a total of 272 units of plasma, and four TACO reactions in separate patients (4.8%) were identified, none of which were reported to the blood bank. The prevalence rate of TACO in the prospective study was 1 in 68 (95% CI, 1:250-1:27). In total, most patients (14/24) were in the intensive care unit when they experienced TACO and on average they had received 4.0±2.3 units of plasma at an average rate of 647±315 mL/hr before the TACO reaction.
CONCLUSIONS: Passive reporting of TACO grossly underestimates its actual prevalence. Educational efforts are needed to enhance physician recognition of TACO reactions.
© 2011 American Association of Blood Banks.

Entities:  

Mesh:

Year:  2011        PMID: 21762464     DOI: 10.1111/j.1537-2995.2011.03247.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  50 in total

1.  Contemporary Risk Factors and Outcomes of Transfusion-Associated Circulatory Overload.

Authors:  Nareg H Roubinian; Jeanne E Hendrickson; Darrell J Triulzi; Jerome L Gottschall; Michael Michalkiewicz; Dhuly Chowdhury; Daryl J Kor; Mark R Looney; Michael A Matthay; Steven H Kleinman; Donald Brambilla; Edward L Murphy
Journal:  Crit Care Med       Date:  2018-04       Impact factor: 7.598

2.  Plasma transfusions prior to insertion of central lines for patients with abnormal coagulation.

Authors:  David P Hall; Lise J Estcourt; Carolyn Doree; Sally Hopewell; Marialena Trivella; Timothy S Walsh
Journal:  Cochrane Database Syst Rev       Date:  2015-06-20

3.  Safety of Factor XIII Concentrate: Analysis of More than 20 Years of Pharmacovigilance Data.

Authors:  Cristina Solomon; Wolfgang Korte; Dietmar Fries; Inna Pendrak; Christine Joch; Albrecht Gröner; Ingvild Birschmann
Journal:  Transfus Med Hemother       Date:  2016-08-03       Impact factor: 3.747

4.  Prophylactic Plasma Transfusion Is Not Associated With Decreased Red Blood Cell Requirements in Critically Ill Patients.

Authors:  Matthew A Warner; Arun Chandran; Gregory Jenkins; Daryl J Kor
Journal:  Anesth Analg       Date:  2017-05       Impact factor: 5.108

5.  Uses and abuses of fresh-frozen plasma for the prophylaxis of bleeding.

Authors:  M J Desborough; S J Stanworth
Journal:  Clin Med (Lond)       Date:  2013-04       Impact factor: 2.659

6.  Active Hemovigilance Significantly Improves Reporting of Acute Non-infectious Adverse Reactions to Blood Transfusion.

Authors:  Naveen Agnihotri; Ajju Agnihotri
Journal:  Indian J Hematol Blood Transfus       Date:  2015-07-16       Impact factor: 0.900

Review 7.  Plasma transfusions prior to lumbar punctures and epidural catheters for people with abnormal coagulation.

Authors:  Lise J Estcourt; Michael J Desborough; Carolyn Doree; Sally Hopewell; Simon J Stanworth
Journal:  Cochrane Database Syst Rev       Date:  2017-09-25

8.  Incidence and clinical characteristics of transfusion-associated circulatory overload using an active surveillance algorithm.

Authors:  N H Roubinian; J E Hendrickson; D J Triulzi; J L Gottschall; D Chowdhury; D J Kor; M R Looney; M A Matthay; S H Kleinman; D Brambilla; E L Murphy
Journal:  Vox Sang       Date:  2016-12-21       Impact factor: 2.144

Review 9.  Reversal of novel oral anticoagulants in patients with major bleeding.

Authors:  Deborah M Siegal; Adam Cuker
Journal:  J Thromb Thrombolysis       Date:  2013-04       Impact factor: 2.300

10.  Incidence of transfusion reactions: a multicenter study utilizing systematic active surveillance and expert adjudication.

Authors:  Jeanne E Hendrickson; Nareg H Roubinian; Dhuly Chowdhury; Don Brambilla; Edward L Murphy; Yanyun Wu; Paul M Ness; Eric A Gehrie; Edward L Snyder; R George Hauser; Jerome L Gottschall; Steve Kleinman; Ram Kakaiya; Ronald G Strauss
Journal:  Transfusion       Date:  2016-07-26       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.